Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
GOLDEN MEDITECH HOLDINGS LIMITED(Incorporated in the Cayman Islands with limited liability)
(Stock Code: 00801) PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL
The Board proposes to increase the authorised share capital of the Company from
HK$600,000,000 to HK$1,000,000,000 by the creation of an additional
2,000,000,000 Shares which will rank pari passu in all respect with all the existing Shares. Immediately upon the Share Capital Increase becoming effective, the authorised share capital of the Company will be HK$1,000,000,000 divided into
5,000,000,000 Shares.
The Share Capital Increase is subject to the approval of the Shareholders by way of an ordinary resolution at the AGM.
A circular containing, among other things, further details of the Share Capital Increase and the notice convening the AGM will be despatched by the Company to the Shareholders as soon as practicable.
The current authorised share capital of the Company is HK$600,000,000 which is currently divided into 3,000,000,000 Shares, and the existing issued share capital of HK$365,474,929.80 divided into 1,827,374,649 Shares. In order to have sufficient authorised share capital to cater for the issue of Shares upon exercise of outstanding derivatives issued by the Company and to accommodate future expansion and growth, the Board proposes to increase the authorised share capital of the Company from HK$600,000,000 to HK$1,000,000,000 by the creation of an additional
2,000,000,000 Shares which will rank pari passu in all respect with all
- 1 -
the existing Shares. Immediately upon the Share Capital Increase becoming effective, the authorised share capital of the Company will be HK$1,000,000,000 divided into
5,000,000,000 Shares.
The Share Capital Increase is subject to the approval of the Shareholders by way of an ordinary resolution at the AGM.
The AGM will be convened and held for the Shareholders to consider and, if thought fit, approve, among other things, the Share Capital Increase. A circular containing, among other things, further details of the Share Capital Increase and the notice convening the AGM will be despatched to the Shareholders as soon as practicable.
DEFINITIONS
In this announcement, unless the context requires otherwise, the following expressions have the following meanings:
"AGM" the annual general meeting of the Company to be held at No. 4 Yong Chang North Road, Beijing Economic Technological Development Area, Beijing, China on Friday, 31 July 2015 at 10:00 a.m. or any adjournment thereof
"Board" board of Directors
"Company" Golden Meditech Holdings Limited, a company incorporated in the Cayman Islands with limited liability and whose shares are listed on the main board of the Stock Exchange
"Director" directors of the Company
"HK$" Hong Kong dollars, the lawful currency of Hong Kong
"Hong Kong" the Hong Kong Special Administrative Region of the
People's Republic of China
"Share(s)" ordinary share(s) of HK$0.20 each in the share capital of the Company
- 2 -
"Share Capital
Increase"
the proposed increase in authorised share capital of the Company from HK$600,000,000 to HK$1,000,000,000 by the creation of an additional 2,000,000,000 Shares
"Shareholder(s)" holder(s) of the Share(s)
"Stock Exchange" The Stock Exchange of Hong Kong Limited
By order of the Board
Chairman
Hong Kong, 30 June 2015
As at the date of this announcement, the Board comprises 9 Directors. The executive Directors are Mr. Kam Yuen (Chairman), Mr. Kong Kam Yu and Mr. Yu Kwok Kuen, Harry, the non-executive Directors are Ms. Zheng Ting and Mr. Gao Yue and the independent non-executive Directors are Prof. Cao Gang, Mr. Feng Wen, Prof. Gu Qiao and Mr. Daniel Foa.
- 3 -
|
distributed by
|
